Suboptimal response for AL amyloidosis: is it time for early switch? Experience from a single amyloid program

Amyloid. 2022 Sep;29(3):208-209. doi: 10.1080/13506129.2022.2055459. Epub 2022 Mar 26.

Authors

Robert Puckrin¹, Holly Lee¹, Jason Tay^{1

2}, Peter Duggan^{1

2}, Sylvia McCulloch¹, Paola Neri^{1

2}, Nizar Bahlis^{1

2}, Victor H Jimenez-Zepeda^{1

2}

Affiliations

¹ Department of Medical Oncology and Hematology, Tom Baker Cancer Center, Calgary, AB, Canada.
² Charbonneau Cancer Research Institute, Calgary, AB, Canada.

PMID: 35341414
DOI: 10.1080/13506129.2022.2055459

No abstract available

Publication types

Letter

MeSH terms

Amyloid
Amyloidogenic Proteins
Amyloidosis*
Humans
Immunoglobulin Light-chain Amyloidosis*

Substances

Amyloid
Amyloidogenic Proteins